Phase 2 Study of Talimogene Laherparepvec in Combination with Pembrolizumab in Subjects with Unresectable/Metastatic Stage IIIB-IVM1d Melanoma Who Have Progressed on Prior Anti PD-1 Based Therapy

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann, (Project Manager)

Project: Research

StatusActive
Effective start/end date12/12/19 → 31/12/24
View all
View less

Keywords

  • Melanoma
  • Medical oncology
  • Clinical trial